← Back to patent-cliff list
Hypochlorous Acid
Tier C — Watch / tradeHypochlorous Acid
Realm Therapeutics
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NF-κB
Brand：Avenova
Indications (approved)：白内障, 眼内炎, Viral infection, COVID-19, Allergic conjunctivitis, Atopic dermatitis
Regional status
US
Phase III
2020-10-29
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Hypochlorous Acid?
Approved indications include: 白内障, 眼内炎, Viral infection, COVID-19, Allergic conjunctivitis, Atopic dermatitis.
When does the Hypochlorous Acid patent expire?
No public expiry year is available for Hypochlorous Acid yet; this page updates once verified.
How do I get a quote for Hypochlorous Acid intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06